Artia Global Partners’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Artia Global Partners's PALI Position: Q3 2026 in Review
Artia Global Partners sold out of Palisade Bio (PALI) in Q3 2026, closing a stake of 1,992,367 shares — an estimated $4.16M sold.
Artia Global Partners first reported a position in PALI in Q4 2025 and held it in 3 quarters. The position peaked at $4.68M in Q4 2025. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Artia Global Partners reported no remaining Palisade Bio position as of Q3 2026 after selling out during the quarter.
- Artia Global Partners sold 1,992,367 Palisade Bio shares in Q3 2026, an estimated $4.16M.
- Artia Global Partners first reported a position in Palisade Bio in Q4 2025 and held it in 3 quarters.
- Artia Global Partners's Palisade Bio position peaked at $4.68M in Q4 2025.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Artia Global Partners's 13F filing for Q3 2026, filed 16 Nov 2026.